| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 634.1  |
1-year : | 740.63 |
| Resists | First : | 542.9 |
Second : | 634.1 |
| Pivot price | 449.17 |
|||
| Supports | First : | 450.63 |
Second : | 393.6 |
| MAs | MA(5) : | 497.25 |
MA(20) : | 446.1 |
| MA(100) : | 389.27 |
MA(250) : | 344.33 |
|
| MACD | MACD : | 18.3 |
Signal : | 7.9 |
| %K %D | K(14,3) : | 93.3 |
D(3) : | 91.1 |
| RSI | RSI(14): 77.8 |
|||
| 52-week | High : | 542.9 | Low : | 265 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MDGL ] has closed It is unclear right now based on current values. 143.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 505.35 - 506.85 | 506.85 - 508.52 |
| Low: | 481.65 - 483.46 | 483.46 - 485.47 |
| Close: | 492.67 - 495.42 | 495.42 - 498.49 |
Tue, 11 Nov 2025
Will MDGL stock pay special dividends - July 2025 Chart Watch & Safe Entry Point Identification - newser.com
Tue, 11 Nov 2025
Will MDGL stock pay special dividends - July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Tue, 11 Nov 2025
Madrigal Pharmaceuticals (MDGL) Receives Buy Rating and Price Ta - GuruFocus
Tue, 11 Nov 2025
Why Madrigal Pharmaceuticals (MDGL) Is Up 20.3% After Positive Two-Year Rezdiffra Data in MASH Cirrhosis - simplywall.st
Mon, 10 Nov 2025
Is MDGL stock a buy for dividend growth - Oil Prices & Precise Buy Zone Identification - newser.com
Sun, 09 Nov 2025
Can MDGL stock hit record highs again - July 2025 Gainers & Pattern Based Trade Signal System - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 1.098e+007 (%) |
| Held by Institutions | 7.6 (%) |
| Shares Short | 4,140 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.084e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -54.7 % |
| Operating Margin | -22.2 % |
| Return on Assets (ttm) | -18.4 % |
| Return on Equity (ttm) | -36.3 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 13.81 |
| Sales Per Share | 14.29 |
| EBITDA (p.s.) | -19.1 |
| Qtrly Earnings Growth | -12.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -307 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 37.53 |
| Price to Cash Flow | -17.65 |
| Dividend | 0 |
| Forward Dividend | 3.69e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|